About Biotangents
Biotangents is a company based in Edinburgh (United Kingdom) founded in 2015.. Biotangents has raised $5.62 million across 5 funding rounds from investors including Gov.uk, Scottish Enterprise and Eos. The company has 13 employees as of December 31, 2021. Biotangents offers products and services including AmpliSpec LAB Mastitis and AmpliSpec LAB BVDV. Biotangents operates in a competitive market with competitors including RareCyte, BioLife Solutions, Sequenta, Heska and seqWell, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 13 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotangents Limited
- Date of Incorporation 21 Jan, 2015
- Jurisdiction PENICUIK, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.62 M (USD)
in 5 rounds
-
Latest Funding Round
$2.9 M (USD), Series A
Nov 28, 2024
-
Investors
Gov.uk
& 5 more
-
Employee Count
13
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biotangents
Biotangents offers a comprehensive portfolio of products and services, including AmpliSpec LAB Mastitis and AmpliSpec LAB BVDV. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid identification of bovine mastitis pathogens in cattle samples.
Detection of Bovine Viral Diarrhoea virus in cattle for disease control.
Unlock access to complete
Unlock access to complete
Funding Insights of Biotangents
Biotangents has successfully raised a total of $5.62M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.9 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $2.9M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series A - Biotangents | Valuation | Eos Advisory | |
| May, 2022 | Amount | Seed - Biotangents | Valuation | Scottish Enterprise | |
| May, 2022 | Amount | Debt – Conventional - Biotangents | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biotangents
Biotangents has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Scottish Enterprise and Eos. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in science and technology is managed by Eos.
|
Founded Year | Domain | Location | |
|
Private debt investment firm focused on SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biotangents
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biotangents
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biotangents Comparisons
Competitors of Biotangents
Biotangents operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RareCyte, BioLife Solutions, Sequenta, Heska and seqWell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for pet care
|
|
| domain | founded_year | HQ Location |
NGS-based reagents and kits are supplied for life sciences research.
|
|
| domain | founded_year | HQ Location |
Provider of technologies and solutions genomic research and precision medicine
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biotangents
Frequently Asked Questions about Biotangents
When was Biotangents founded?
Biotangents was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Biotangents located?
Biotangents is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Is Biotangents a funded company?
Biotangents is a funded company, having raised a total of $5.62M across 5 funding rounds to date. The company's 1st funding round was a Seed of $745.99K, raised on Jun 01, 2017.
How many employees does Biotangents have?
As of Dec 31, 2021, the latest employee count at Biotangents is 13.
What does Biotangents do?
Biotangents was founded in 2015 in Edinburgh, United Kingdom, within the biotechnology sector focused on veterinary diagnostics. Products are offered for detecting bovine viral diarrhea through RNA-specific sections, utilizing Moduleic Sensing technology. This approach employs modular target-amplifier-reporter constructs to create nucleic acid detectors for animal health applications, supporting diagnostics in the veterinary field.
Who are the top competitors of Biotangents?
Biotangents's top competitors include Neogen, Paragon Genomics and RoosterBio.
What products or services does Biotangents offer?
Biotangents offers AmpliSpec LAB Mastitis and AmpliSpec LAB BVDV.
Who are Biotangents's investors?
Biotangents has 6 investors. Key investors include Gov.uk, Scottish Enterprise, Eos, British Business Investments, and Kelvin Capital.